Biosino Biotechnology Company Ltd is a high-technology enterprise whose major national controlling stakeholders comprise the Chinese Academy of Sciences, Beijing Municipal Government and Shanghai Municipal Government. Through the development, production and retail of diagnostic products, Biosino has become the largest manufacturer of diagnostic biochemical assay kits in China. Formerly established in 1988 as Beijing Zhong Sheng Bio-engineering High Technology Company, it was a national enterprise under the auspices of the Chinese Academy of Sciences Institute of Biophysics. In 2001, the Chinese Academy of Sciences Institute of Biophysics backed the re-launch of the company. With investment from Chuangkou Enterprises in Hong Kong owned by Beijing Municipal Government and from Shanghai Municipal Government's Lianchuang Investment Company, together with a new name, Biosino Biotechnology Company Ltd. was established.

Since its inception, Biosino has taken the lead within China in creating a series of mono- and double- reagent diagnostic products, successfully developing a series of more than 90 assay sets directed at conditions such as hepatitis, coronary artery disease, diabetes and hyperlipidemia. Our series of over 200 standard mono- and double- reagent diagnostic tests has been consistently recognized over the years to be a leading product from the Beijing New Technology Pilot Industrial Development Zone. What is more, our enterprise has been listed as one of the top 50 "New Technology Tigers", achieving recognition for our products as a famous brand nationally...